US What the potential Covid-19 booster rollout could look like
Union urges NFL to adopt daily COVID-19 testing for vaccinated players
There’s a decent chance that the COVID-19 pandemic will play more of a role during the 2021 NFL season than last year. We’re seeing relaxed protocols from the league as it relates to fully vaccinated players with Week 1 of the campaign slated to get going Thursday evening. It has already led to some COVID-related issues for teams. That includes star guard Zack Martin and the Dallas Cowboys with their opener against the Tampa Bay Buccaneers mere days away. Despite being fully vaccinated, Martin tested positive for the virus and will miss the game.NFLPA president JC Tretter of the Cleveland Browns touched on this recently.
It's not clear if or when boosters doses of Covid-19 vaccines will be OK'd for fully vaccinated people in the United States, but state and local health departments across the United States are moving ahead with plans for a potential rollout next week.
Last month, US health officials announced plans for booster doses of Covid-19 vaccine to be offered starting the week of September 20, subject to sign-off from the US Food and Drug Administration and the US Centers for Disease Control and Prevention.
Astros right-hander Zack Greinke confirms he tested positive for COVID-19
Greinke has slowly been working his way back to the mound and will start Tuesday's game against the Texas Rangers.Greinke provided an update Saturday, saying he, his wife and two sons all tested positive for COVID-19, adding that all four are fully vaccinated, per Chandler Rome of the Houston Chronicle.
Those conversations are getting underway this week, including a key meeting of FDA vaccine advisers on Friday, but the decision isn't a slam dunk, experts have said.
Still, those tasked with administering boosters can't wait for the details to be finalized.
"We don't want to be unprepared," Lori Tremmel Freeman, chief executive officer of the National Association of County and City Health Officials, told CNN on Wednesday.
She said that local health departments are planning now to be ready after the FDA review's Pfizer data -- especially, as they already are "really overwhelmed" right now with responding to surges of Covid-19 cases, working to get the unvaccinated vaccinated, and preparing for the flu season.
The last thing local health officials need at the moment is more chaos or confusion, but many of their questions around boosters still have not been answered: "What is the interval for boosters? Is it any shorter than eight months at this point? What is the age cut-off? Will there be priority groupings?" Freeman said. "We don't want to appear uncoordinated on boosters."
Questions and answers on Biden's new booster shot plan
After months of debate, the Biden administration announced Wednesday that they plan to begin offering booster shots starting the week of Sept. 20 for all Americans who received the Pfizer or Moderna vaccines.The announcement that people are recommended to get booster shots eight months following their second vaccine dose prompts an array of questions, including objections from some experts who doubt that everyone needs them.Others are askingThe announcement that people are recommended to get booster shots eight months following their second vaccine dose prompts an array of questions, including objections from some experts who doubt that everyone needs them.
What has to happen before boosters go into arms?
The FDA'swill meet this Friday to discuss whether support the idea of giving a booster dose to people 16 and older about six months after they complete their second dose. And there will be more steps before boosters will be OK'd to go into arms of the general public.
"It's important to note that the FDA's role is really to say can we use this -- can we use this product or can we use this booster. It's the CDC who will decide whether or not they should be used," Dr. Anna Durbin, director of theat the Johns Hopkins Bloomberg School of Public Health, said during a virtual briefing on Wednesday.
"So even if FDA comes out and approves the use of boosters by saying they're safe, and they do what they're supposed to do, the CDC will still need to review and approve the use of boosters to say that they're actually needed, and who they are needed for and it may be that they recommend it for different populations -- the elderly, for instance, or people in nursing homes, we don't know," she said.
COVID-19 booster debate rages days before target rollout date
The debate over COVID-19 booster shots for all Americans remains intense with less than a week to go before the target rollout date desired by the White House and days before government advisers plan to vote on the issue. Experts are eagerly parsing the data on booster shots after internal feuding at the Food and […] The post COVID-19 booster debate rages days before target rollout date appeared first on Roll Call.
US health officials have maintained they want to stay ahead of the virus -- but not get ahead of US health agencies.
"No one's going to get boosters until the FDA says they're approved, until the CDC advisory committee makes a recommendation. What we want to do though is be ready as soon as that comes," White House chief of staffon "State of the Union" earlier this month.
"A hundred percent we will wait for FDA approval, we will wait for CDC approval."
Klain said that even if boosters of both shots don't receive full approval before September 20, the administration would still be ready to distribute them by then.
What could distribution look like for additional doses?
The rollout plan for boosters won't quite resemble earlier vaccination efforts, where pharmacies went to nursing homes to vaccinate residents and stadiums held long lines of people waiting for shots at mass vaccination sites.
"There's still a lot of emphasis on pharmacies to continue to play a strong role in administering vaccine, and over 70% of doses are currently administered to pharmacies," NACCHO's Freeman said, but she added that in some states, certain pharmacies and hospitals may not participate in the booster programs because they won't have the staffing capacity to do so, among other reasons.
Why the FDA made the right call on Covid booster shots
Protecting already vaccinated Americans from contracting mild Covid shouldn't be more important than the lives and human rights of people in poorer countries.The idea of ramping up booster shots has come under sharp criticism from scientific authorities around the globe, including the director-general of the World Health Organization and leading journals such as Nature and Science, due to extreme global vaccine inequity and the unclear benefits of providing booster shots on such a wide scale. Hopefully the decision on Friday, though not binding, will cause Biden to rethink his plans.
In those cases, boosters could be administered at other sites, such as doctor's offices or specific vaccine clinics.
"It could look differently state by state," Freeman said, but she emphasized that there is "no limitation" or constraints on vaccine supply.
Rather, "we have been hearing from local health departments, without any confirmed information coming their way, they are beginning to assess who on the ground will have the capacity to do boosters, who will remain as a provider of vaccines and who is pulling out -- so that we have a better understanding of how the community will be served and by whom," Freeman said. "There's just a lot of some confusion about this."
How many people might be eligible for boosters?
It's not clear what parameters the US booster program will have, if it launches at all.
The Biden administration previously said US residents would be eligible for a third dose of Covid-19 vaccine eight months after receiving their second dose.
In that case, up toto receive a booster shot, or third dose, of a Covid-19 vaccine during the week of September 20, if the booster program began then.
Data from the CDC shows that about 3.4 million US residents were fully vaccinated by January 20, which would make them eligible for a booster shot eight months later on September 20. Up to 5.2 million people may be eligible for their booster shot by the end of the week.
Report: Buccaneers' Antonio Brown positive for COVID-19, unlikely to play at Rams
Brown is fully vaccinated against COVID-19, meaning he can return to team activities if he stays asymptomatic and produces two negative virus tests 24 hours apart. Nevertheless, Arians added he's preparing as if both Brown and Minter won't be available against the Rams. Brown leads Tampa Bay with 23.0 yards per catch on six receptions and is second on the team with 138 receiving yards this season. He caught one touchdown over the first two games of the campaign, both Tampa Bay wins. The Rams are also 2-0 on the campaign. Subscribe to Yardbarker's Morning Bark, the most comprehensive newsletter in sports.
The initial booster rollout is on track to include Pfizer/BioNTech doses -- pending authorization from the FDA -- but it may take a few weeks longer to move forward with boosters of Moderna's vaccine.
More than half, 56%, of the doses administered by January 20 were Pfizer/BioNTech doses, data from the CDC shows. In December, the FDA authorized the Pfizer/BioNTech vaccine for emergency use about a week before the Moderna vaccine.
Public health officials and medical experts at thein August that the booster rollout could be phased by default since the initial rollout of first doses was phased.
For instance, if the boosters are recommended for people six to eight months after receiving their second dose, health care workers and older adults would likely will be the first eligible group to receive booster shots if a rollout happens next week.
If someone received their second dose in January, that was eight months ago. March was six months ago.
"At that time, the individuals who were fully vaccinated earliest in the vaccination rollout, including many health care providers, nursing home residents, and other seniors, will likely be eligible for a booster," the statement said. "We would also begin efforts to deliver booster shots directly to residents of long-term care facilities at that time, given the distribution of vaccines to this population early in the vaccine rollout and the continued increased risk that COVID-19 poses to them."
The FDA and CDC previously signed off on allowing third doses for people who are immunocompromised. More than 1.9 million people have already received an additional dose since mid-August, according to the CDC.
Booster confusion takes hold as Biden announces expanded eligibility .
"We have the tools to beat Covid if we come together as a country and use the tools we have," Biden said.Biden said his administration will begin to deliver booster shots after the nation’s two leading health agencies endorsed a third dose of the Pfizer-BioNtech vaccine for people 65 and older and those at elevated risk of severe Covid-19. The announcement is the culmination of weeks of debate inside the administration about whether data showed that vaccine efficacy was waning enough to begin to roll out doses to large swathes of the country.